OLAPLEX GC equity cancelled in Henkel merger
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OLAPLEX HOLDINGS, INC. General Counsel John C. Duffy reported dispositions tied to the company’s merger with Henkel US Operations Corporation. At the merger’s effective time, his 971,384 common shares were converted into the right to receive $2.06 per share in cash.
The filing also notes 803,173 shares underlying his restricted stock units were cancelled and converted into the same cash consideration. In addition, 170,000 stock options with exercise prices of $5.41 and $14.95 per share were cancelled for no consideration, leaving him with no reported remaining shares or options.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Company Stock Options | 85,000 | $0.00 | $0.00 |
| Disposition | Company Stock Options | 85,000 | $0.00 | $0.00 |
| Disposition | Common Stock | 971,384 | $2.06 | $2.00M |
Footnotes (4)
- F1. Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated March 26, 2026, by and among the Issuer, Henkel US Operations Corporation ("Parent"), and Margot Acquisition Merger Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Merger" and, together with the other transactions contemplated by the Merger Agreement, the "Transactions"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock of the Issuer (each, a "Share") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $2.06 per Share in cash (the "Merger Consideration"), without interest, subject to any withholding of taxes required by applicable law.
- F2. At the Effective Time, each award of restricted stock units covering Shares granted under the Issuer's 2021 Equity Incentive Plan, the Issuer's Amended & Restated 2020 Omnibus Equity Incentive Plan, or any other effective equity or equity-based incentive plan sponsored by the Issuer or its affiliates (collectively, the "Company Equity Plans") (each such award, a "Company RSU Award") that was outstanding immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company RSU Award, multiplied by (y) the Merger Consideration. The amount reported includes 803,173 Shares underlying the Reporting Person's Company RSU Awards, which were automatically cancelled and converted into the right to receive the Merger Consideration at the Effective Time.
- F3. At the Effective Time, each option to purchase Shares granted under the Issuer's Company Equity Plans (each, a "Company Option") that was outstanding and unexercised immediately prior to the Effective Time (whether vested or unvested) was, by virtue of the Merger, automatically cancelled and converted into the right to receive (without interest) an amount in cash equal to the product of (x) the aggregate number of Shares underlying such Company Option, multiplied by (y) the excess, if any, of the Merger Consideration over the per Share exercise price of such Company Option; provided, however, that any Company Option that had a per Share exercise price that was equal to or greater than the Merger Consideration was cancelled for no consideration.
- F4. (Continued from footnote 3) The Reporting Person held Company Options in two tranches: (i) 85,000 Company Options with a per Share exercise price of $14.95 and (ii) 85,000 Company Options with a per Share exercise price of $5.41. Both exercise prices exceeded the Merger Consideration of $2.06 per Share. Accordingly, all 170,000 of the Reporting Person's Company Options were cancelled for no consideration at the Effective Time.
Key Figures
Key Terms
Agreement and Plan of Merger regulatory
Merger Consideration financial
restricted stock units financial
Company RSU Award financial
Company Option financial
Equity Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did OLAPLEX (OLPX) report for John C. Duffy?
How were John C. Duffy’s OLAPLEX (OLPX) restricted stock units treated in the merger?
What happened to John C. Duffy’s OLAPLEX (OLPX) stock options in the merger?
How were OLAPLEX (OLPX) equity awards generally treated under the merger agreement?
AI-generated analysis. How Rhea-AI works. Not financial advice.